« Return to News | Study Conduct

Survey: Researchers Value Training

Wednesday, July 21, 2010 08:58 AM

ePharmaSolutions, a Philadelphia, Pa.-based provider of clinical research services, has completed a research survey of over 205 clinical researchers in 18 countries who administer psychometric rating scales to measure the improvement or worsening of symptoms in psychiatric and neurologic clinical trials. Survey highlights: 82% prefer to be trained by a scale author or someone expert in the field, and 90% feel interview skills training prior to site activation helps improve the ability to accurately rate subjects. “Some of the results were quite fascinating and provide much better insight into the global needs of site raters,” said Dr. Theresa Bromley, ePharmaSolutions’ associate director of rater services. The company conducts several research surveys with investigative sites every year to help improve site adoption of its technologies and services. It provides niche clinical services to help improve the way sites are selected, trained, activated and supported to commence clinical trials and meet enrollment goals. ePharmaSolutions has activated and trained more than 185,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies around the world.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.